Display options
Cite
Niknam R, Mousavi S, Safarpour A, et al. Self-medication of irritable bowel syndrome and dyspepsia: How appropriate is it?. J Res Pharm Pract. 2016;5(2):121-5doi: 10.4103/2279-042X.179576.
Niknam, R., Mousavi, S., Safarpour, A., Mahmoudi, L., & Mahmoudi, P. (2016). Self-medication of irritable bowel syndrome and dyspepsia: How appropriate is it?. Journal of research in pharmacy practice, 5(2), 121-5. https://doi.org/10.4103/2279-042X.179576
Niknam, Ramin, et al. "Self-medication of irritable bowel syndrome and dyspepsia: How appropriate is it?." Journal of research in pharmacy practice vol. 5,2 (2016): 121-5. doi: https://doi.org/10.4103/2279-042X.179576
Niknam R, Mousavi S, Safarpour A, Mahmoudi L, Mahmoudi P. Self-medication of irritable bowel syndrome and dyspepsia: How appropriate is it?. J Res Pharm Pract. 2016 Apr-Jun;5(2):121-5. doi: 10.4103/2279-042X.179576. PMID: 27162806; PMCID: PMC4843581.
Copy Download .nbib Format: NLM
Share it on

J Res Pharm Pract. 2016 Apr-Jun;5(2):121-5. doi: 10.4103/2279-042X.179576.

Self-medication of irritable bowel syndrome and dyspepsia: How appropriate is it?.

Journal of research in pharmacy practice

Ramin Niknam, Sarah Mousavi, Alireza Safarpour, Laleh Mahmoudi, Paria Mahmoudi

Affiliations

  1. Gastroenterohepatology Research Center, Shiraz, Fasa, Iran; Department of Internal Medicine, Fasa University of Medical Sciences, Fasa, Iran.
  2. Department of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran.
  3. Gastroenterohepatology Research Center, Shiraz, Fasa, Iran.
  4. Department of Clinical Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.
  5. Pharmaceutical Science Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

PMID: 27162806 PMCID: PMC4843581 DOI: 10.4103/2279-042X.179576

Abstract

OBJECTIVE: Self-medication is common among patients with gastrointestinal (GI) symptoms. This study was performed to evaluate self-medication among patients who fulfilled irritable bowel syndrome (IBS) and dyspepsia diagnostic criteria and to investigate the appropriateness of self-medication with chemical and herbal drugs.

METHODS: A prospective, descriptive cross-sectional study was conducted in outpatient's GI clinics at Shiraz from November 2011 to May 2012. A GI specialist visited the patients and recruited those who had IBS (base on Rome III adapted criteria) or functional dyspepsia. We surveyed self-medication among these patients, using a questionnaire containing specific questions about self-medication.

FINDINGS: One thousand four hundred and forty-seven patients visited by the GI specialist during the study period. Seven hundred and forty-seven patients had the inclusion criteria, 337 of them fulfilled criteria for IBS, with IBS-mixed (52%) being the most prevalent subtype, and 410 patients had dyspepsia. Overall, 78.8% of the total participants had recently sought medical attention for their GI complaint. Twenty-eight percent of patients selected inappropriate medication for their GI complaints. The H2-blockers class were most common medicines reportedly used. We did not find any significant relationship between age, gender, level of education, marital status, and self-medication frequency.

CONCLUSION: Patients who fulfilled criteria for IBS had a high tendency to self-treat their GI symptoms, use of acid-suppressive agents was common among patients. Around one-third of patients self-treated GI symptoms inappropriately. Consequently, the concept of self-medication among patients has to be revised. We recommend conduction of educational programs to improve self-medications selection and attitude among patients to reduce the burden on other health care resources.

Keywords: Dyspepsia; Iran; irritable bowel syndrome; self-medication

References

  1. Int J Prev Med. 2012 Mar;3(Suppl 1):S18-25 - PubMed
  2. Med Care. 1990 Apr;28(4):301-10 - PubMed
  3. J Basic Clin Pharm. 2013 Dec;5(1):19-23 - PubMed
  4. Arch Iran Med. 2013 Oct;16(10):580-3 - PubMed
  5. Aliment Pharmacol Ther. 2001 Sep;15(9):1263-70 - PubMed
  6. J Gastrointestin Liver Dis. 2006 Sep;15(3):237-41 - PubMed
  7. Int J Clin Pharm. 2012 Aug;34(4):561-8 - PubMed
  8. Iran J Public Health. 2014 Feb;43(2):136-46 - PubMed
  9. Scand J Gastroenterol. 1997 Sep;32(9):855-61 - PubMed
  10. World J Gastroenterol. 2014 Jul 21;20(27):8796-806 - PubMed
  11. Chin J Dig Dis. 2006;7(4):181-5 - PubMed
  12. Soc Sci Med. 2002 Jun;54(12):1875-86 - PubMed
  13. Int J Prev Med. 2012 Mar;3(Suppl 1):S1-9 - PubMed
  14. J Manag Care Pharm. 2008 Nov-Dec;14(9):870-7 - PubMed

Publication Types